Resona Asset Management Co. Ltd. Reduces Stock Position in Xylem Inc. $XYL

Resona Asset Management Co. Ltd. cut its stake in Xylem Inc. (NYSE:XYL) by 5.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 80,235 shares of the industrial products company’s stock after selling 4,925 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Xylem were worth $10,958,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in XYL. AQR Capital Management LLC increased its holdings in Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after buying an additional 3,900 shares in the last quarter. NewEdge Advisors LLC grew its position in shares of Xylem by 3.3% in the first quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after purchasing an additional 132 shares during the last quarter. Empowered Funds LLC grew its position in shares of Xylem by 56.1% in the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Xylem by 97.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after purchasing an additional 5,509 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after purchasing an additional 635 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Up 1.6%

Shares of NYSE XYL opened at $108.08 on Thursday. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The firm’s 50 day moving average price is $119.40 and its 200 day moving average price is $131.61. The firm has a market cap of $25.69 billion, a P/E ratio of 26.88, a price-to-earnings-growth ratio of 1.51 and a beta of 1.08. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The firm had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. During the same quarter last year, the business earned $1.03 earnings per share. Xylem’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.6%. Xylem’s dividend payout ratio (DPR) is currently 42.79%.

Xylem declared that its board has authorized a share buyback program on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Analysts Set New Price Targets

XYL has been the topic of several research reports. Jefferies Financial Group reiterated a “hold” rating and issued a $130.00 price target (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. The Goldman Sachs Group set a $158.00 price target on shares of Xylem in a research report on Wednesday, February 11th. Mizuho set a $138.00 price target on shares of Xylem in a research report on Wednesday, February 11th. Stifel Nicolaus lowered their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Finally, UBS Group raised their target price on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and an average target price of $152.77.

Insider Buying and Selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the purchase, the director owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.32% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.